Myrbetriq Dosage Chart

Understanding Myrbetriq and Its Dosing Requirements

Myrbetriq (mirabegron) is a prescription medication used to treat overactive bladder symptoms such as frequent urination, urgency, and incontinence. This beta-3 adrenergic agonist works by relaxing the bladder muscle, thereby increasing bladder capacity and reducing unwanted contractions. Understanding the proper dosage is essential for achieving optimal results while minimizing potential side effects.

The medication comes in multiple formulations, including extended-release tablets for adults and oral granules for pediatric patients. Proper dosing depends on several factors, including age, weight, kidney function, and liver health. This comprehensive dosage chart will guide you through all approved dosing recommendations.

Standard Adult Myrbetriq Dosage Chart

For adults with an overactive bladder, Myrbetriq follows a straightforward dosing schedule designed to maximize effectiveness while ensuring safety.

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

Initial Adult Dosing

The recommended starting dose for adults is:

• 25 mg once daily taken with or without food
• Swallow tablets whole with water
• Do not chew, divide, or crush tablets
• Take at the same time each day for consistency

Dose Escalation Schedule

If the initial 25 mg dose does not provide adequate symptom relief after 4 to 8 weeks, your healthcare provider may increase the dose:

• 50 mg once daily is the maximum dose for most adults
• Increase only after evaluating efficacy and tolerability at 25 mg
• Most patients experience symptom improvement within 8 weeks

Combination Therapy Dosing

Myrbetriq is also approved in combination with solifenacin for patients who need additional symptom control. This combination therapy follows specific dosing guidelines:

Starting Combination Dose

• Myrbetriq 25 mg plus solifenacin 5 mg once daily
• Both medications can be taken at the same time
• Can be taken with or without food

Combination Dose Adjustment

• After 4 to 8 weeks, Myrbetriq may be increased to 50 mg once daily
• Solifenacin dose typically remains at 5 mg daily
• Adjustments based on individual response and side effects

Pediatric Myrbetriq Dosage Chart

Myrbetriq is approved for children aged 3 years and older with neurogenic detrusor overactivity, a condition often associated with spinal cord injuries or neurological disorders. Pediatric dosing is weight-based and available in both tablet and oral granule formulations ².

Pediatric Tablet Dosing (Children ≥35 kg)

For children weighing 35 kg or more who can swallow tablets whole:

• Starting dose: 25 mg once daily
• Maximum dose: 50 mg once daily after 4 to 8 weeks if needed
• Same administration guidelines as adults

Pediatric Oral Granule Dosing

The oral granule formulation allows for weight-based dosing in younger children:

Children ≥35 kg:

• Starting dose: 6 mL once daily
• Maximum dose: 10 mL once daily after 4 to 8 weeks

Children 22 kg to <35 kg:

• Starting dose: 4 mL once daily
• Maximum dose: 8 mL daily

Children 11 kg to <22 kg:

• Starting dose: 3 mL once daily
• Maximum dose: 6 mL daily

Special Population Dosing Adjustments

Certain medical conditions require dose modifications to ensure safety and prevent drug accumulation.

Kidney Function Impairment

Patients with reduced kidney function need careful dose adjustment:

• Mild kidney impairment: No dose adjustment needed
• Moderate kidney impairment: No dose adjustment needed
• Severe kidney impairment (eGFR 15-29 mL/min/1.73m²): Do not exceed 25 mg once daily
• End-stage renal disease: Not recommended

Liver Function Impairment

Liver problems can affect how the body processes Myrbetriq:

• Mild liver impairment: No dose adjustment needed
• Moderate liver impairment (Child-Pugh B): Do not exceed 25 mg once daily
• Severe liver impairment: Not recommended

Important Administration Guidelines

Proper administration ensures optimal absorption and effectiveness while reducing the risk of side effects.

Timing and Food

• Take at the same time each day to maintain consistent blood levels
• Can be taken with or without food
• If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose
• Never take two doses at the same time to make up for a missed dose

Extended-Release Tablets

Extended-release tablets must remain intact to work properly:

• Swallow tablets whole with water
• Do not chew, crush, or divide tablets
• Crushing destroys the extended-release mechanism
• Contact your pharmacist if you have trouble swallowing tablets

Response Timeline

Understanding when to expect results helps patients and healthcare providers make informed dosing decisions.

Initial Response Period

Most patients begin experiencing symptom improvement within the first few weeks of treatment:

• Symptom relief typically begins within 2 to 3 weeks
• Full benefits usually achieved by 8 weeks
• Individual response times may vary

Dose Adjustment Timing

• Healthcare providers typically wait 4 to 8 weeks before increasing the dose
• This allows time to assess both effectiveness and tolerability
• Premature dose increases may lead to unnecessary side effects

Possible Side Effects

Understanding side effect patterns helps patients know what to expect at different doses.

Common Side Effects

These effects occur in more than 2% of patients and are generally mild:

• High blood pressure (most common)
• Urinary tract infections
• Headache
• Common cold symptoms
• Constipation
• Upper respiratory tract infections

Serious but Rare Side Effects

These effects occur in less than 1% of patients but require immediate medical attention:

• Severe allergic reactions
• Difficulty urinating or inability to empty bladder completely
• Severe increases in blood pressure
• Abnormal heart rhythms

Drug Interactions Affecting Dosage

Certain medications can affect Myrbetriq blood levels, potentially requiring dose adjustments.

Medications That Increase Myrbetriq Levels

• Strong CYP2D6 inhibitors may require dose reduction
• Discuss all medications with your healthcare provider
• Include over-the-counter supplements and herbal products

Medications That Decrease Effectiveness

• Some enzyme-inducing medications may reduce Myrbetriq’s effectiveness
• Your doctor may need to adjust dosing or timing
• Never stop or start medications without medical guidance

Myrbetriq can also affect how other medications work. For example, it can raise the levels of digoxin (Lanoxin) or warfarin (Coumadin) in your body. This can increase your risk of side effects.

Monitoring and Follow-Up

Regular monitoring ensures safe and effective treatment with appropriate dose adjustments when needed.

Initial Monitoring Period

• Blood pressure checks within the first few weeks
• Assessment of symptom improvement at 4 to 8 weeks
• Review of any side effects or concerns

Long-Term Monitoring

• Regular blood pressure monitoring for all patients
• Kidney function tests for patients with existing kidney problems
• Ongoing assessment of symptom control and quality of life

Making Myrbetriq More Affordable

The cost of Myrbetriq can be high, especially for long-term treatment. Several strategies can help reduce out-of-pocket expenses while ensuring access to this effective medication.

Insurance coverage varies significantly between plans, and many patients find their copays higher than expected. For those seeking more predictable pricing, cash-pay options through Universal Drugstore can provide transparent, often lower-cost access to Myrbetriq. This approach eliminates insurance complexities and can be particularly valuable for patients with high-deductible plans or those between insurance coverage periods.

When to Contact Your Healthcare Provider

Certain situations require prompt medical attention or dose adjustments.

Contact Immediately

• Difficulty urinating or inability to empty your bladder
• Severe allergic reactions (rash, swelling, difficulty breathing)
• Significant increases in blood pressure
• Chest pain or irregular heartbeat

Schedule Follow-Up

• No improvement in symptoms after 8 weeks at your current dose
• Bothersome side effects that don’t improve
• Questions about dose timing or administration
• Need for other medications that might interact

This comprehensive Myrbetriq dosage chart provides essential information for safe and effective treatment of overactive bladder symptoms. Always follow your healthcare provider’s specific instructions, as individual circumstances may require modifications to standard dosing recommendations. Regular communication with your medical team ensures optimal results while maintaining safety throughout your treatment journey.

References

• Myrbetriq- mirabegron tablet, film coated, extended release; Myrbetriq- mirabegron granule, for suspension, extended release [package insert]. Astellas Pharma US, Inc.  Last updated 4/2021. Accessed July 2, 2026.
• Mirabegron (Oral Route) Proper Use. Mayo Clinic. Accessed July 2, 2026.
• Myrbetriq Dosing Information for Healthcare Professionals. Astellas Pharma. Accessed July 2, 2026.
• Mirabegron (Myrbetriq) – Drug Information. Medscape. Accessed July 2, 2026.